Work

Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest

Year: 2015
Type: article
Abstract: // Michela Capello 1, 2, 7, * , Sammy Ferri-Borgogno 1, 2, 8, * , Chiara Riganti 3 , Michelle Samuel Chattaragada 1, 2 , Moitza Principe 1, 2 , Cecilia Roux 1, 2 , Weidong Zhou 4 , Emanuel F. Petricoin 4 , Paola Cappello 1, 2, 5 , Francesco Novelli 1, 2, 5, 6 1 Department of Molecular Biotechnologies and Health Sciences, University of Turin, Turin 10126, Italy 2 Center for Experimental Research and Medical Studies, University Hospital Città della Salute e della Scienza di Torino, Torino 10126, Italy 3 Department of Oncology, University of Turin, Turin 10126, Italy 4 Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA 5 Molecular Biotechnology Center, Turin 10126, Italy 6 Immunogenetics and Transplantation Biology Service, University Hospital Città della Salute e della Scienza di Torino, Torino 10126, Italy 7 Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA 8 Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA * These authors contributed equally to this work Correspondence to: Francesco Novelli, e-mail: [email protected] Keywords: alpha-enolase, cancer metabolism, Warburg effect, cellular senescence Received: July 18, 2015 Accepted: December 05, 2015 Published: December 30, 2015 ABSTRACT In the last 5 years, novel knowledge on tumor metabolism has been revealed with the identification of critical factors that fuel tumors. Alpha-enolase (ENO1) is commonly over-expressed in tumors and is a clinically relevant candidate molecular target for immunotherapy. Here, we silenced ENO1 in human cancer cell lines and evaluated its impact through proteomic, biochemical and functional approaches. ENO1 silencing increased reactive oxygen species that were mainly generated through the sorbitol and NADPH oxidase pathways, as well as autophagy and catabolic pathway adaptations, which together affect cancer cell growth and induce senescence. These findings represent the first comprehensive metabolic analysis following ENO1 silencing. Inhibition of ENO1, either alone, or in combination with other pathways which were perturbed by ENO1 silencing, opens novel avenues for future therapeutic approaches.
Source: Oncotarget
Language: English
Subfield: Cancer Research
Open Access status: diamond
OpenAlex ID: W2253051214
FWCI: 2.356
Cites: 43
Cited by: 160
Related to: 10